KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other Working Capital Changes (2018 - 2025)

Historic Other Working Capital Changes for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $395476.0.

  • Adaptive Biotechnologies' Other Working Capital Changes fell 4316.21% to $395476.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $395476.0, marking a year-over-year decrease of 4316.21%. This contributed to the annual value of $765392.0 for FY2024, which is 108.31% up from last year.
  • Latest data reveals that Adaptive Biotechnologies reported Other Working Capital Changes of $395476.0 as of Q3 2025, which was down 4316.21% from $336998.0 recorded in Q2 2025.
  • Over the past 5 years, Adaptive Biotechnologies' Other Working Capital Changes peaked at $695796.0 during Q3 2024, and registered a low of -$14.2 million during Q1 2021.
  • Moreover, its 5-year median value for Other Working Capital Changes was $19626.0 (2021), whereas its average is -$3.6 million.
  • In the last 5 years, Adaptive Biotechnologies' Other Working Capital Changes plummeted by 10550.1% in 2021 and then surged by 221426.91% in 2022.
  • Quarter analysis of 5 years shows Adaptive Biotechnologies' Other Working Capital Changes stood at -$11.4 million in 2021, then dropped by 9.63% to -$12.5 million in 2022, then skyrocketed by 51.03% to -$6.1 million in 2023, then surged by 72.31% to -$1.7 million in 2024, then soared by 123.37% to $395476.0 in 2025.
  • Its last three reported values are $395476.0 in Q3 2025, $336998.0 for Q2 2025, and -$3.3 million during Q1 2025.